Corporate Banner
Satellite Banner
AgriGenomics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Gentronix Extends Toxicology Screening Services to Apoptosis

Published: Tuesday, August 13, 2013
Last Updated: Monday, August 12, 2013
Bookmark and Share
Company adds apoptosis testing to provide follow-up for micronucleus positive results.

Apoptosis, or programmed cell death, is used by the body to remove unwanted, damaged or senescent cells from tissues. Gentronix has announced the expansion of its service testing portfolio with the launch of Apoptosis Suite: a set of in vitro assays to detect apoptosis induction during micronucleus assessment.

New compounds being developed as pharmaceuticals, agrichemicals etc are subject to genotoxicity assessment in order to identify potential carcinogenicity.

However, positive genotoxicity results alone need not terminate the development of a compound. One reason for this is that some genotoxicity tests have recognized mechanisms for the generation of misleading, or ‘false positive’ results.

For example, the widely used micronucleus test can produce positive results as a consequence of ‘apoptosis’, which can be induced by both genotoxic and non-genotoxic mechanisms.

Thus when a compound produces a positive micronucleus test result, it is valuable to understand the context of the result in relation to cytotoxicity and apoptosis induction.

Activation of apoptotic pathways at similar doses to those inducing micronucleus formation can provide valuable weight of evidence in de-risking the positive result. This would then trigger the application of other genotoxicity test methods, such as the Ames test, GreenScreen HC or BlueScreen HC assays.

A positive Apoptosis suite result, combined with a negative Ames test or GreenScreen HC / BlueScreen HC result would suggest apoptosis may be the cause of a misleading positive result in the in vitro micronucleus test.

The Apoptosis Suite comprises of: an Annexin-V Affinity Assay, a Caspase 3/7 Assay and general cytotoxicity measures covering cellular proliferation and viability.

Phosphatidylserine (PS) is a phospholipid that is normally only present on the inner leaflet of cell membranes, but during apoptosis it is translocated to the extracellular membrane leaflet, marking the cell as a target for phagocytosis.

Fluorescently labelled recombinant Annexin-V preferentially binds to the translocated PS and is detected using flow cytometry. Caspases are proteases that play a key role in apoptosis in mammalian cells.

Adding a luminogenic Caspase 3/7 substrate results in cell lysis followed by caspase cleavage with an attendant ‘glow-type’ luminescence that is proportional to the amount of caspase activity present.

The combination of these assays, alongside general cellular toxicity measures, provides strong evidence for the presence or absence of an apoptotic mechanism.

Dr Steve Beasley, Commercial Director at Gentronix, commented: “Our Apoptosis Suite is a powerful tool to help determine the context of a positive genotoxicity result identified during early micronucleus test screening. This latest addition to our service offering highlights our commitment to expanding our range of assays and services in line with our customers’ needs. It enables toxicologists to better assess screening results and where necessary modify candidate compounds to eliminate genotoxicity, while still keeping the desired active properties.”


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,200+ scientific posters on ePosters
  • More than 4,600+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
“Amazing Protein Diversity” Discovered in Maize
The genome of the corn plant – or maize, as it’s called almost everywhere except the US – “is a lot more exciting” than scientists have previously believed. So says the lead scientist in a new effort to analyze and annotate the depth of the plant’s genetic resources.
Invasive Species Could Cause Billions in Agriculture Damages
Invasive insects and pathogens could be a multi-billion-dollar threat to global agriculture and developing countries may be the biggest target, according to a team of international researchers.
Genetic Research Can Significantly Improve Drug Development
With drug development costs topping $1.2bn (£850 million) to get a single treatment to the point it can be sold and used in the clinic, could genetic analysis save hundreds of millions of dollars?
What Makes a Good Scientist?
It’s the journey, not just the destination that counts as a scientist when conducting research.
Scoliosis Linked to Disruptions in Spinal Fluid Flow
A new study in zebrafish suggests that irregular fluid flow through the spinal column brought on by gene mutations is linked to a type of scoliosis that can affect humans during adolescence.
More Research Needed to Ensure Gene Drive Safety
Gene-Drive modified organisms are not ready to be released into environment a new report calls for more research and robust assessment.
Genetic Basis of Petunia Variation Uncovered
A large international team of researchers, including scientists from Wageningen University, have now sequenced the entire genome of two different wild petunia species, and published this in the important scientific journal Nature Plants.
Genetically Engineered Crops Are Safe
Distinction between genetic engineering and conventional plant breeding becoming less clear, says new report on GE crops.
Breeding More Climate Resilient Brassicas
Scientists at the John Innes Centre have discovered how a gene that helps determine plant flowering time could help us breed better brassicas in the face of climate change.
One Step Closer To Developing Non-Allergenic 'Super' Peanuts
Scientists from The University of Western Australia have joined a global research team that have identified genes in peanuts that when altered will be able to prevent an allergic response in humans.
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,200+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,600+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!